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Abstract
Background: Tankyrases are poly(adenosine diphosphate)-ribose polymerases that contribute to biological processes
as diverse as modulation of Wnt signaling, telomere maintenance, vesicle trafficking, and microtubule-dependent
spindle pole assembly during mitosis. At interphase, polarized reshaping of the microtubule network fosters oriented
cell migration. This is attained by association of adenomatous polyposis coli with the plus end of microtubules at the
cortex of cell membrane protrusions and microtubule-based centrosome reorientation towards the migrating front.
Results: Here we report a new function for tankyrases, namely, regulation of directional cell locomotion. Using a panel
of lung cancer cell lines as a model system, we found that abrogation of tankyrase activity by two different, structurally
unrelated small-molecule inhibitors (one introduced and characterized here for the first time) or by RNA interference-
based genetic silencing weakened cell migration, invasion, and directional movement induced by the motogenic
cytokine hepatocyte growth factor. Mechanistically, the anti-invasive outcome of tankyrase inhibition could be ascribed
to sequential deterioration of the distinct events that govern cell directional sensing. In particular, tankyrase blockade
negatively impacted (1) microtubule dynamic instability; (2) adenomatous polyposis coli plasma membrane targeting;
and (3) centrosome reorientation.
Conclusions: Collectively, these findings uncover an unanticipated role for tankyrases in influencing at multiple levels
the interphase dynamics of the microtubule network and the subcellular distribution of related polarity signals. These
results encourage the further exploration of tankyrase inhibitors as therapeutic tools to oppose dissemination and
metastasis of cancer cells.
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Background
In the last decade two enzymes belonging to the poly(ade-
nosine diphosphate)-ribose polymerase (PARP) superfam-
ily, tankyrase 1 (TNKS) and 2 (TNKS2), were identified as
key regulators of spindle pole assembly through poly(ade-
nosine diphosphate)-ribosylation (PARsylation) of several
microtubule-related proteins within the spindle apparatus
[1, 2]. Poly (adenosine diphosphate)-ribose (PAR) units
have also been accredited as integral spindle constituents,
with TNKS and TNKS2 (TNKS/2 hereinafter) being the
prime regulators of spindle-associated PAR synthesis [3].
TNKS/2 downregulation is consistently reported to yield
aberrant mitotic phenotypes, including microtubule
defects and supernumerary spindles [4]. TNKS/2 are also
required for proper sister telomere resolution [5] and
centrosome function [6, 7]. Altogether, these observations
added to the archetypal function of these enzymes as posi-
tive regulators of telomere homeostasis [8, 9] and spurred
a growing interest in neutralizing their activity to induce
spindle dysfunction and disable the mitotic engine in
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cancer cells [10, 11]. Independent studies have also shown
that TNKS/2 positively regulate the Wnt/β-catenin signal-
ing pathway. In particular, TNKS/2 have been reported to
inhibit the β-catenin destruction complex by promoting
the degradation of its rate-limiting component, axin1 [12].
Consequently, β-catenin remains unbridled and is allowed
to enter the nucleus, where its gene program is released
[12].
The multifaceted activities exerted by tankyrases can be
explained by the vast number and heterogeneity of puta-
tive TNKS/2 substrates: in silico analyses have put forward
hundreds of candidates [13], some of which—including
mitotic regulators, transcription factors, and signaling
adaptors—have been validated as true TNKS/2 binders by
classic protein–protein interaction assays [13–17]. How-
ever, the biological relevance of most such interactions still
require experimental scrutiny, suggesting that other, as yet
unappreciated, functions of TNKS/2 will emerge soon.
In this work, we provide evidence of a novel role for
TNKS/2 in regulating directional migration. By using two
distinct and structurally unrelated inhibitors, including a
new investigational compound for which we provide
original structural, pharmacological, and biochemical
characterization, we found that abrogation of TNKS/2
activity markedly weakened cancer cell motility owing
to perturbation of recognized microtubule-dependent
routes that govern cell-oriented locomotion. The find-
ing that TNKS/2 blockade impacts microtubule-based
cellular processes not only at mitosis but also in
interphase cells expands our knowledge about TNKS/
2 functions at the cellular level and should hasten the
preclinical development of TNKS/2 inhibitors for ap-
plicative purposes.
Results
Structural, pharmacological, and biochemical
characterization of JNJ-BJ, a novel TNKS/2 inhibitor
XAV939 is a pyrimidine derivative that inhibits TNKS/2 by
binding to the nicotinamide pocket of the enzymes, with
half-maximal inhibitory concentrations (IC50) of 0.011 μM
and 0.004 μM, respectively [12, 18]. JNJ-BJ is the first
eluted enantiomer of a 3-ethylquinolinone (1A) and, like
XAV939, competes with nicotinamide binding to tan-
kyrases. When tested in an auto-PARsylation assay against
the recombinant, baculovirus-expressed PARP domain of
TNKS2, JNJ-BJ displayed an IC50 of 0.13 μM (pIC50 6.88;
Fig. 1b). Details on the compound synthesis scheme are
provided in Additional file 1.
A characteristic readout of TNKS/2 inhibition is a reduc-
tion in β-catenin-dependent signaling in cells with a hyper-
active Wnt pathway [12]. Coherent with the inhibitory
activity towards purified TNKS2, treatment of adenomatous
polyposis coli (APC)-mutant DLD1 colorectal cancer cells
with JNJ-BJ impaired Wnt-driven transcriptional responses,
as assessed by both a TOPflash luciferase reporter assay
(Fig. 1c; raw data in Additional file 2) and reverse transcrip-
tion quantitative polymerase chain reaction (RT-qPCR)
analysis of the expression of established β-catenin target
genes (Fig. 1d; raw data in Additional file 2). As expected,
and in accordance with previous findings [12], similar
results were obtained with XAV939 (Fig. 1c, d; raw data in
Additional file 2).
TNKS/2 inhibition hampers lung cancer cell invasion and
migration in response to hepatocyte growth factor
Although mutations of APC or β-catenin are infre-
quent in lung cancer, hyperactivation of the Wnt
pathway, as evidenced by transcriptional overexpres-
sion of Wnt-responsive genes, has been documented
in samples from aggressive lung adenocarcinomas
[19]. Because TNKS/2 are accredited upstream regula-
tors of the Wnt pathway [12], we initially pursued the
idea that interception of TNKS/2 activity might pre-
vent Wnt-induced lung cancer cell dissemination. As
a first step, we explored the consequences of TNKS/2
blockade on cell motility in four lung adenocarcinoma
cell lines—H322, HCC827, H460, and A549—using
XAV939 and JNJ-BJ as tool compounds.
To provide proof of concept that TNKS/2 blockade
was proficient in lung cancer, A549 cells were treated
with increasing concentrations of XAV939 or JNJ-BJ for
24 h and assessed for expression of axin1, which is typic-
ally stabilized by TNKS/2 inhibition owing to impaired
TNKS/2-mediated PARsylation and consequent protein
degradation [12]. Western blot analysis of total cell ex-
tracts revealed that both compounds were able to in-
duce a dose-dependent increase of axin1 protein
content (Fig. 2a), indicating successful TNKS/2 inacti-
vation. Remarkably, when challenged in Matrigel-
coated Transwell systems using hepatocyte growth
factor (HGF) as a chemoattractant [20], A549 cells ex-
hibited a dose-dependent reduction in invasive ability
following TNKS/2 inactivation by XAV939 or JNJ-BJ
(Fig. 2b; raw data in Additional file 3).
Analyses were subsequently extended to the remaining
lung cancer cell lines by applying the dose that yielded
maximal invasion impairment in the setup experiments
(10 μM). In the case of XAV939, 5–10 μM is the standard
inhibitor concentration commonly used in biological stud-
ies [21, 22]. Consistent with that observed in A549, axin1
was invariably stabilized upon treatment with either com-
pound (Fig. 2c). Similarly, TNKS/2 inactivation compro-
mised HGF-induced chemotactic response to a
comparable extent in all the cell lines tested, apart from a
weaker activity of XAV939 in H322 (Fig. 2d; raw data in
Additional file 3). A decrease in cell invasion was paral-
leled by reduced migration in wound healing (scratch) as-
says. With the exception of H460 cells (which proved
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unsuitable for production of a compact monolayer and
were therefore excluded), abrogation of TNKS/2 activity
markedly dampened HGF-induced wound closure
competence (Fig. 2e; raw data in Additional file 3).
It is worth noting that in these cells we did not
observe noticeable anti-proliferative effects following
TNKS/2 inhibition, even after a 72 h exposure to
drugs (Additional file 4: Figure S1; raw data in Add-
itional file 5). This result is at odds with the estab-
lished mitotic function of TNKS/2, but is congruent
with previous observations showing that TNKS/2
pharmacological inhibition is much less detrimental
to cell proliferation than RNA interference (RNAi)-
based silencing [4, 5, 12, 21]. Whatever the explan-
ation for this discrepancy, which remains a matter of
debate [2, 12, 21], these findings suggest that mecha-
nisms other than a mere growth disadvantage are im-
plicated in the reduced cell motility observed in
response to TNKS/2 blockade.
We also employed RNAi as an alternative means of
inactivating TNKS/2. In agreement with pharmacologic
experiments, productive co-depletion of TNKS and
TNKS2 in A549 cells (Additional file 6: Figure S2A and
S2B; raw data in Additional file 7) resulted in axin1
stabilization (Additional file 6: Figure S2B) and reduced
cell invasion (Additional file 6: Figure S2C; raw data in
Additional file 7). Likewise, wound closure ability was
lessened by RNAi-mediated TNKS/2 silencing in A549
cells (Additional file 6: Figure S2D; raw data in
Additional file 7). Although genetic knockdown of
TNKS/2 has been shown to affect cell proliferation, the
time frame of Transwell and scratch assays (24 h) was
likely sufficiently short not to bias the anti-invasive out-
come of TNKS/2 abrogation. In summary, impaired cell
invasion proved to be a direct function of increasing
compound concentrations and was achieved by two
structurally different inhibitors; moreover, TNKS/2
genetic silencing recapitulated the biochemical and
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Fig. 1 Structural, pharmacological, and biochemical characterization of JNJ-BJ. a Chemical structure of JNJ-BJ. The compound is the first eluted
enantiomer of a 3-ethylquinolinone bearing a chiral center linked to the C-7 carbon atom ((R or S)-3-[2-cyano-2-(3-ethyl-2-oxo-1H-quinolin-7-yl)propyl]-
benzonitrile). b Tankyrase (TNKS) autoribosylation assay. A recombinant His-tagged human TNKS2 poly(adenosine diphosphate)-ribose polymerase
domain was produced in a baculovirus/insect cell expression system. The purified protein was bound to a 384-well Ni2+-coated Flashplate and incubated
for 120 min with NADH3/NAD in the presence of increasing concentration of JNJ-BJ. The radioactive signal was measured using a scintillation reader.
c Assessment of β-catenin/TCF transcriptional activity through a TOPflash reporter assay in adenomatous polyposis coli-mutant DLD1 colorectal cancer
cells. Cells were treated with TNKS/2 inhibitors (10 μM) for 24 h. Results are expressed as TOP/FOP ratio and represent the average (lines) ± range of two
independent experiments (diamonds), each performed in technical quadruplicate. d Expression of AXIN2 and LGR5 transcripts in DLD1 cells treated with
TNKS/2 inhibitors (10 μM) for 24 h. Results are the average (lines) of two independent experiments (diamonds), each performed in technical triplicate.
Raw data for panels c and d are shown in Additional file 2. DMSO dimethyl sulfoxide, IC50 half-maximal inhibitory concentrations
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Fig. 2 (See legend on next page.)
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biological effects of pharmacologic inhibition. These
findings indicate that the impaired chemotactic response
is a specific consequence of TNKS/2 disruption.
The anti-invasive outcome of TNKS/2 inhibition is independ-
ent of the Wnt pathway
The anti-invasive and anti-migratory effects produced by
TNKS/2 neutralization were consistent with the working
hypothesis that blockade of TNKS/2 activity would blunt
Wnt-mediated pro-invasive cues. We therefore analyzed
whether this weakened chemotactic response was in fact
ascribable to interception of Wnt signaling.
First, the TOPflash reporter system was employed to
gauge Wnt-dependent transcriptional responses after
cell exposure to TNKS/2 inhibitors (for this purpose, we
used H322 cells owing to their high amenability to trans-
fection procedures). We found that TNKS/2 inhibition
did not affect Wnt transcriptional activity, either ba-
sally or upon addition of the canonical Wnt ligand
Wnt3a (Additional file 8: Figure S3A; raw data in
Additional file 9). As a complementary approach, ex-
pression of established Wnt target genes was assessed by
RT-qPCR in the whole panel of lung adenocarcinoma cell
lines tested in the cell invasion experiments. As shown in
Additional file 8: Figure S3B (raw data in Additional file
9), stimulation with Wnt3a led to increased expression of
at least some of the target genes, with variable levels of in-
duction in the various cell lines (likely due to cell type-
specific differences). Also in this experimental setting, and
consistent with the TOPflash assay, cell line-dependent
transcription of Wnt3a target genes was not detectably in-
fluenced by treatment with TNKS/2 inhibitors (Additional
file 8: Figure S3B; raw data in Additional file 9). Finally,
Transwell assays demonstrated that cell invasion was not
evidently fostered by Wnt3a (Additional file 8: Figure S3C;
raw data in Additional file 9), further supporting the ir-
relevance of Wnt signaling to TNKS/2-related migratory
phenotypes in our cellular models.
All in all, Wnt-dependent activities did not substan-
tially enhance cell motility in lung cancer cell lines, nor
were they clearly impacted by TNKS/2 inactivation. This
implies that the observed effects on migration and
invasion likely rely on alternative mechanisms.
TNKS/2 inhibition impacts the dynamics of formation of
cell membrane protrusions
To get better insight into how cell motogenic re-
sponses were impacted by TNKS/2 abrogation,
wounded A549 monolayers were treated with HGF
and monitored for 1 h using time-lapse videomicro-
scopy in the presence or absence of JNJ-BJ, which
was selected as the best performing compound in
preliminary experiments (see Fig. 2e). Single images
were captured every 12 s to allow for distinct
visualization of the migration process (Additional file
10: Movie M1). Figure 3a shows representative time-
lapse snapshots, captured 15, 30, and 60 min after
HGF stimulation. We noticed that the dynamics of
protrusion formation at the wound edge were discern-
ibly slowed by JNJ-BJ. In particular, control cells dis-
played pronounced membrane ruffling, characterized
by repetitive and vigorous bursts of incipient projec-
tions at the leading edge (Fig. 3a, white arrows); by
contrast, protrusive activity appeared flimsier and
membrane extensions subsided quickly in cells treated
with JNJ-BJ. Besides the stronger propulsive flows,
control cells also developed numerous circular dorsal
ruffles (Fig. 3a, yellow arrows), whose function gener-
ally implies transition from a static to a motile
phenotype [23]; conversely, the formation of such
structures was almost completely prevented by JNJ-BJ
(Fig. 3a and Additional file 10: Movie M1).
On the basis of such observations, we assumed
that TNKS/2 inhibition impaired cell movement by
negatively impacting migration dynamics at the lead-
ing edge. To complement the time-lapse qualitative
information, we quantified membrane extensions in
(See figure on previous page.)
Fig. 2 Tankyrase 1 and 2 (TNKS/2) inhibition by XAV939 or JNJ-BJ impairs hepatocyte growth factor (HGF)-dependent cell migration and invasion
in non-small cell lug cancer (NSCLC) cells. a Western blot showing the amount of axin1 in total protein extracts from A549 cells treated with a
range of concentrations of XAV939 or JNJ-BJ for 24 h. Actin was used as a loading control. Molecular weights are indicated. b Dose-dependent inhib-
ition of HGF-induced invasion in A549 cells by treatment with increasing concentrations of XAV939 or JNJ-BJ (HGF, 50 ng/mL). Quantification was car-
ried out by ImageJ software. TNKSi TNKS/2 inhibitor. Data are the means (lines) ± standard error of the mean (SEM) of three independent experiments
(diamonds), each performed in technical duplicate. c Western blot analysis showing the levels of axin1 in whole-cell extracts from the indicated NSCLC
cell lines. Before protein extraction, cells were incubated with 10 μM XAV939 or JNJ-BJ for 24 h. Actin was used as a loading control. Molecular weights
are indicated. d ImageJ quantification of HGF-induced invasion in the indicated cell lines upon TNKS/2 blockade (HGF, 50 ng/mL; TNKS/2 inhibitors,
10 μM). Data are the means (lines) ± SEM of three or four independent experiments (diamonds), each performed in technical duplicate. e Representa-
tive images of a scratch assay performed with the indicated cell lines in the following experimental conditions (from left to right): non-stimulated con-
trol wound (Day 0); HGF-treated cells 24 h after wounding (HGF, 50 ng/mL); HGF-treated and XAV939/JNJ-BJ-treated cells 24 h after wounding (HGF,
50 ng/mL; TNKS/2 inhibitors, 10 μM). Plots on the right depict ImageJ quantification of wound repair inhibition 24 h after scratch. Data are the means
(lines) ± SEM of three independent experiments (diamonds), each performed in technical duplicate or triplicate. *P < 0.05; **P < 0.01; ***P < 0.001 by
two-tailed Student’s t-test (TNKSi-treated versus untreated [dimethyl sulfoxide, DMSO]). Raw data for panels b, d, and e are shown in Additional file 3
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HGF-stimulated A549 cells with or without TNKS/2 in-
hibitors. As shown in Fig. 3b (raw data in Additional file
11), the proportion of protruding cells was signifi-
cantly decreased by either compound after 15 and
30 min of HGF exposure. Remarkably, the curves
related to TNKS/2-inhibited cells tended to re-align
with the curve of control cells after 1 h, suggesting
that TNKS/2 blockade hindered early rather than late
events of cell migration.
TNKS/2 inhibition enhances microtubule stability in
interphase cells
TNKS/2 couple with the mitotic microtubule circuitry
to affect spindle structure and function [4]. As specified
earlier, this is accomplished through interaction with
various microtubule-related proteins as well as with
other spindle-associated targets [1, 2, 4, 15]. We rea-
soned that analogous functional connections might be
extended to interphase microtubule-dependent activities,
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Fig. 3 Inactivation of tankyrase 1 and 2 (TNKS/2) weakens protrusive activity and lamellipodia formation. a Phase-contrast snapshots extracted from a
1 h time-lapse movie of wounded A549 monolayers treated with hepatocyte growth factor (HGF; 50 ng/mL) in the presence or absence of JNJ-BJ
(10 μM). White arrows indicate membrane projections; yellow arrows label circular dorsal ruffles. See Additional file 10: Movie M1 for complete
visualization. Scale bar, 7 μm. b Quantitation of membrane protrusions in HGF-stimulated wound-edge A549 cells with or without TNKS/2 inhibitors
(see “Methods” for details; HGF, 50 ng/mL; XAV939 and JNJ-BJ, 10 μM). Results are expressed as the percentage of protrusion-positive cells ± standard
error of the mean. A minimum of 163 cells was counted for each experimental point in three independent experiments (P < 0.001 by two-way analysis
of variance). Raw data for panel b are shown in Additional file 11. DMSO dimethyl sulfoxide
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whose dynamics are intimately related to polarized cell
migration [24, 25].
Inception of oriented cell movement entails microtubule-
dependent reorganization of the cellular architecture to
establish a rear–front axis. This asymmetric pattern is
supported by the inherent instability of microtubules,
which constantly undergo rounds of shrinkage and re-
growth [26]. To investigate whether TNKS/2 neutralization
interfered with microtubule dynamic instability, we decon-
structed the microtubule network in A549 cells by cold
treatment (4 °C, 6 min) or nocodazole (1 μM, 5 min).
Under basal conditions, microtubules were intact and their
organization was similar in both untreated and TNKS/2-
inhibited cells (Fig. 4a, b and Additional file 12: Figure S4;
raw data for Fig. 4b in Additional file 13). Notably, cold-
induced or nocodazole-induced microtubule disassembly
was widespread in control cells whereas it was markedly
prevented in cells treated with XAV939 or JNJ-BJ (Fig. 4a,
b and Additional file 12: Figure S4; raw data for Fig. 4b in
Additional file 13). This indicates that microtubules were
rendered more stable by TNKS/2 inactivation. RNAi-
mediated TNKS/2 depletion recapitulated the phenotype
produced by TNKS/2 pharmacologic inactivation (Add-
itional file 14: Figure S5).
The finding that TNKS/2 blockade increased the pro-
portion of stable microtubules suggests that TNKS/2 in-
hibition might obstruct microtubule-dependent activities
implicated in cell polarity and directional migration.
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Fig. 4 The microtubule network is stabilized by tankyrase 1 and 2 (TNKS/2) pharmacological neutralization. a Confocal images and b
morphometric quantitation of the microtubule network at standard temperature (37 °C) or after cold (4 °C) exposure. Starved A549 cells were
pre-incubated for 24 h with or without TNKS/2 inhibitors (10 μM) and then placed on ice for 6 min (cold treatment) before immediate fix-
ation and staining with anti-α-tubulin antibody. Scale bar, 7 μm. Images are representative of one experiment out of two performed. A minimum of
52 cells from at least two different fields were analyzed for content of polymerized tubulin. ***P < 0.001 by two-tailed Student’s t-test. NS not significant.
Raw data for panel b are shown in Additional file 13. DMSO dimethyl sulfoxide
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TNKS/2 inhibition affects centrosome reorientation in
migrating cells
Microtubule-related activities are central to polarized
cell migration through mechanisms that involve protein
targeting to cortical sites and the generation of pulling
forces that help reorganize cell architecture in response
to chemotactic cues [24, 27, 28]. One hallmark of cell
polarization is the relative orientation of the nuclear-
centrosome axis with respect to the rear–front axis
(which defines the direction of cell migration); in gen-
eral, this alignment is thought to correlate with the onset
of cell migration and to contribute to the establishment
of cell polarity by facilitating membrane trafficking from
both the Golgi and the endocytic recycling compart-
ments towards the leading edge [29]. Centrosome posi-
tioning is largely influenced by microtubule dynamics;
regardless of context-dependent idiosyncratic differ-
ences, it is apparent that during productive cell locomo-
tion the centrosome relocates in front of the nucleus
facing the direction of cell migration [29, 30].
On such premises, we explored whether TNKS/2 in-
hibition could perturb microtubule-dependent establish-
ment of cell asymmetry by measuring the amount of
reoriented centrosomes in wound-edge A549 cells
following induction of migration by HGF. Based on
previously published studies [31], centrosomes were
scored as “fully polarized” if the angle between the
nuclear-centrosome axis (Fig. 5, red arrows) and the
front-back axis (Fig. 5, white arrows) was less than 30°,
which vouches for centrosome dwelling within the
forward-facing quadrant (raw data in Additional file 15).
In HGF-treated cells without TNKS/2 inhibitors, centro-
some location shifted from an essentially random distri-
bution around the nucleus to a biased rearrangement
along the migration axis, with polarization angles reflect-
ing a progressive degree of cell orientation over time
(Fig. 5). The increase of fully polarized centrosomes was
accompanied by a concomitant reduction in the number
of untailored centrosomes displaying angles greater than
60° (Fig. 5). Remarkably, HGF-induced acquisition of the
polarized phenotype was antagonized by treatment with
either TNKS/2 inhibitor. At 1 h after cell wounding,
almost 50 % of control cells were fully polarized,
compared to only 34 % and 29 % of XAV939-treated and
JNJ-BJ-treated cells, respectively; also the decline of non-
polarized centrosomes was not as manifest as that
observed in control cells (Fig. 5). After 4 h, 60 % of
control cells showed fully oriented centrosomes, as
opposed to nearly 40 % of TNKS/2-inhibited cells
(Fig. 5). Akin to TNKS/2 pharmacologic blockade,
genetic knockdown of both TNKS and TNKS2 in
A549 cells disturbed centrosome repositioning upon
HGF stimulus (Additional file 16: Figure S6). Collect-
ively, these results indicate that TNKS/2 inactivation
results in perturbed centrosome reorientation in migrat-
ing cells, with delayed alignment along the rear–front axis.
TNKS/2 inhibition retards APC recruitment at the leading edge
Adenomatous polyposis coli (APC) is a strategic cytoskel-
etal coordinator of migration directionality owing to its re-
cruitment to microtubule-dependent clusters at protrusive
areas. This is thought to regulate microtubule anchoring
at the cell cortex and consequent centrosome rearrange-
ment [32, 33]. With this in mind, we assessed HGF-
induced redistribution of APC in wounded A549 cell
monolayers, either left untreated or exposed to TNKS/2
inhibitors. Immunofluorescence staining showed a diffuse
APC cytoplasmic distribution along with an intense nu-
clear signal (Fig. 6a), consistent with the notion that APC
shuttles between the nucleus and the cytoplasm to assist
β-catenin nuclear export [34]. Immediately after wound-
ing, APC was evenly distributed throughout the cell
monolayer and in cells closely adjacent to the wound area
(Fig. 6a). APC redistribution in cortical clusters at the
wound edge was evident in control cells as early as 15 min
after HGF stimulation and persisted up to 1 h (Fig. 6a). By
contrast, treatment with TNKS/2 inhibitors led to a
marked attenuation of APC membrane targeting at the
15 min time point after HGF stimulation. Morphometric
quantitation revealed that the number of APC-positive
protrusions was reduced by TNKS/2 inactivation also
when normalized against the number of total protru-
sions (Fig. 6b; raw data in Additional file 17). This
indicates that the impairment of APC membrane relo-
calization was not a mere consequence of lessened
membrane ruffling secondary to TNKS/2 blockade. Of
note, the representative curves of control and TNKS/
2-inhibited cells tended to readjust over time: in fact,
APC-decorated lamellipodia were equally represented
at 30 min and 1 h post-wounding in all the condi-
tions tested (Fig. 6a, b). Thus, TNKS/2 inhibition
deferred APC membrane redistribution in response to
HGF, which integrates with our previous data about
retarded centrosome repositioning. The fact that APC
localization in protrusions was only transiently retarded,
whereas centrosome reorientation was impaired for longer
times, is congruent with the notion that, once cell
polarization is established, positive feedback loops initiate
between the actin-rich cortex and the microtubule
cytoskeleton to maintain and reinforce the existing polar-
ity axis [35]. Therefore, while APC relocation is required
for centrosome rearrangement, the persistence of such a
tailored phenotype is likely sustained by processes that
engage proteins and network interactions other than APC,
together with the microtubule cytoskeleton. Remarkably,
impaired accumulation of APC at the protrusive front was
even exacerbated by RNAi-mediated TNKS/2 knockdown;
indeed, HGF-induced recruitment of APC at cortical areas
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Fig. 5 Centrosome reorientation is retarded by tankyrase I and 2 (TNKS/2) inhibitors in migrating cells. Representative confocal images of centrosome
localization in migrating A549 cells. Wound-edge A549 cells, with or without TNKS/2 inhibitors (10 μM), were stimulated with hepatocyte growth factor
(HGF) (50 ng/mL) for 4 h. Immunofluorescence staining of centrosomes was carried out using anti-γ-tubulin antibody. Centrosome polarization was
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was prevented at all the time points in A549 wound-
edge cells transduced with TNKS- and TNKS2- short
hairpin RNAs (Additional file 18: Figure S7).
Finally, to get further insight into how TNKS/2 may
regulate APC-dependent microtubule dynamics, we
analyzed the subcellular distribution of TNKS and APC
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Fig. 6 Tankyrase 1 and 2 (TNKS/2) inhibitors delay the formation of cortical adenomatous polyposis coli (APC) clusters in migrating cells.
a Confocal images of serum-starved, wound-edge A549 cells, either untreated or treated with TNKS/2 inhibitors (10 μM) and then subject to a time course of
hepatocyte growth factor (HGF) stimulation (HGF, 50 mg/mL). Cells were fixed and stained with anti-APC antibody. b Quantitation of APC-decorated protru-
sions. The curves represent APC enrichment in cortical areas over time. Results are expressed as the percentage of APC-positive protrusion ± standard error of
the mean. A minimum of 163 cells was counted for each experimental condition in three independent experiments (P< 0.001 by two-way analysis of
variance). Scale bar, 7 μm. Raw data for panel b are shown in Additional file 17. DMSO dimethyl sulfoxide
Lupo et al. BMC Biology  (2016) 14:5 Page 10 of 15
in migrating A549 cells. We found that both APC and
TNKS were recruited at the leading edge upon HGF
stimulation (Additional file 19: Figure S8). Similar to
APC, TNKS enrichment at membrane protrusions was
impaired in the presence of TNKS/2 inhibitors (Add-
itional file 19: Figure S8). TNKS staining was specific, be-
cause TNKS/2 blockade also induced the formation of
TNKS-enriched puncta, a reported phenotype of TNKS/
2-inhibited cells [36] (Additional file 19: Figure S8).
The fact that TNKS follows subcellular dynamics
similar to those experienced by APC and the experimen-
tal observation that persistent obliteration of TNKS/2 by
genetic silencing durably precludes APC relocation at
the leading edge reinforce the hypothesis that TNKS/2
are implicated in the establishment of cell polarization
during oriented locomotion. Taken together, these obser-
vations allow us to draw a coherent scenario whereby
TNKS/2 blockade appears to interfere sequentially with
regulated events that, in space and time, orchestrate the
establishment of cellular polarity. This perturbation of
cell polarity is facilitated by the enhanced microtubule
stability produced by TNKS/2 inactivation.
Discussion
The PARPs TNKS and TNKS2 were initially identified as
key players in telomere homeostasis through inhibition
of TRF1, a negative regulator of telomere length [8, 9].
Independent lines of evidence also accredited TNKS/2
as positive regulators of microtubule-dependent mitotic
events through their interaction with a number of spin-
dle-associated proteins (which assures proper bipolar
spindle formation) [1, 2] as well as through PARsyla-
tion of key centrosomal targets (which regulates ac-
curate microtubule-aster formation) [6, 7]. Finally,
TNKS/2 have recently been identified as upstream
components of the Wnt/β-catenin pathway, which en-
courages cell proliferation by intensification of β-
catenin transcriptional activities [12]. The notion that
tankyrases have versatile activities in processes that,
when gone awry, invariably lead to aberrant cell
growth, has spurred the development of several
TNKS/2 inhibitors [11, 37, 38].
Here we report a new function of TNKS/2 that does
not involve regulation of cell cycle entry or cell division,
but rather influences cell polarity and directional cell
locomotion. Indeed, we found that pharmacological in-
hibition of TNKS/2 dampens microtubule-dependent
cell chemotactic responses. Because recent data have
linked Wnt transcriptional signatures to the metastatic
competence of lung adenocarcinoma cells [19], our ini-
tial working hypothesis was that the anti-migratory out-
come of TNKS/2 inhibition might be ascribed to
impaired Wnt signaling. However, in our experimental
setup, TNKS/2 inhibition did not substantially affect
Wnt-associated responses and Wnt stimulation did not
detectably promote cell invasion, indicating that the de-
cline of cell motility as a consequence of TNKS/2 inhib-
ition occurred irrespective of Wnt activity. This hints
that TNKS/2-directed drugs are likely to prove effective
as inhibitors of Wnt signals only in those tumors that
display constitutive Wnt activation on a genetic basis,
such as colorectal cancer. Indeed, there is cumulative
evidence that pharmacologic neutralization of TNKS/2
activity proficiently (albeit not uniformly) impairs the
growth of APC-mutant colorectal cancer cells by at-
tenuating Wnt-mediated signals [12, 39, 40].
None of the established functions of TNKS/2 can
explain the less motile phenotype observed in TNKS/2-
inhibited cells. Live imaging of migrating cells allowed
us to detect less intense and less persistent protrusive
activities upon TNKS/2 blockade, likely reflecting differ-
ent cytoskeletal dynamics at the leading edge. On the
one hand, TNKS/2 play a documented role in the regula-
tion of microtubules during mitosis. On the other hand,
many facets of cell protrusions—including orientation
and persistence—are determined by microtubule-related
activities, and disruption of the microtubule network
impairs protruding activity in several cellular contexts
[24, 31, 41–43]. We therefore sought to extend the
connection between TNKS/2 and the microtubule net-
work from mitotic to interphase-related processes, with
a specific focus on whether and how TNKS/2 may influ-
ence microtubule-dependent cell polarization as a prel-
ude to directional movement.
The regulation of microtubule dynamics during cell
polarization is complex. In general, it is believed that a
wide range of polarity cues, including intracellular
signals such as Cdc42 and soluble morphogens such as
motogenic growth factors, converge to activate transduc-
ers that phosphorylate and inhibit glycogen synthase
kinase 3 beta (GSK3β) [24, 44]. This leads to APC inter-
action with the microtubule plus ends at the leading
edge, which stabilizes the microtubule network specific-
ally at the protrusive areas and generates pulling forces
that reorient the centrosome and align it along the rear–
front axis [32]. Successful implementation of all these
events requires consecutive episodes of microtubule
catastrophes (depolymerization) and rescues (repolymer-
ization) in order to grant microtubules with local
“search-and-capture” activity. Accordingly, it has been
demonstrated that several proteins that stall microtubule
dynamics exert anti-invasive effects by preventing micro-
tubules from probing outward, resulting in faulty capture
to cortical sites and reduced receptiveness of chemotactic
inputs [45, 46]. We found that TNKS/2 blockade im-
pacted some of these aspects of cell directional sensing.
First, cells treated with TNKS/2 inhibitors retained a pre-
served microtubule cytoskeleton in the face of disruptive
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stimuli, indicative of enhanced microtubule stabilization.
Second, during HGF-induced migration, TNKS/2-inhib-
ited cells experienced delayed recruitment of APC at the
leading edge. Third, as a consequence of all these interfer-
ences, TNKS/2-inhibited cells showed deteriorated orien-
tation of the centrosome towards the leading edge. Cell
migration relies on sequential waves of protrusive activ-
ities at the leading edge. Therefore, our observation that
membrane projections and APC cortical targeting were
deferred in treated cells can well explain the negative im-
pact of tankyrase inhibition on cell motility as a whole.
The identification of TNKS/2 effectors responsible for
the observed activities on cell polarity and directional
migration will likely prove daunting. The manifold
outcomes of TNKS/2 inhibition, which appear to vary in
different cellular settings and at different moments of
the cell life cycle, illustrate the versatile nature of such
enzymes, which in turn is rooted in the plethora of
potential substrates and interactors. It is therefore
conceivable that TNKS/2 redundantly affect cell migra-
tion by influencing the fate and function of many sub-
strates rather than by selective modulation of one
partner. Although a more precise elucidation of how
such interconnections mechanistically contribute to the
anti-migratory effects of TNKS/2 inhibition awaits fur-
ther studies, our work illuminates new angles in the
evolving landscape of tankyrase-related biology and sets
the stage for widening the potential scope of TNKS/2-
tailored strategies beyond the currently prevailing
paradigms.
Conclusions
Collectively, our results highlight a crucial role for tan-
kyrases in maneuvering the interphase microtubule
apparatus at various levels, from dynamic instability to
localization of polarity signals. These findings add new
layers of information to our current knowledge of tan-
kyrase biology and may inform new approaches for the
preclinical and clinical evaluation of anti-TNKS/2 drugs.
Methods
Cell cultures, reagents, vectors, and viral infection
A549, H460, H322, HCC827, and DLD1 cells were
purchased from ATCC (Manassas, VA) and cultured
in Roswell Park Memorial Institute (RPMI) medium
(Sigma-Aldrich, Saint Louis, MO). Their genetic identity
was validated by short tandem repeat profiling (Cell ID,
PromegaFitchburg, WI). Antibodies were rabbit anti-
tankyrase-1/2, rabbit anti-APC, and goat anti-actin (Santa
Cruz Dallas, TX); rabbit anti-axin1, rabbit anti-phospho-
GSK3-β Ser9, and rabbit anti-GSK3β (Cell Signaling
Danvers, MA); and mouse anti-α-tubulin and mouse anti
γ-tubulin (Sigma). XAV939 and JNJ-BJ were provided by
Janssen Pharmaceutica NV. Recombinant human HGF
and Wnt3a were purchased from Peprotech (Rocky Hill,
NJ) and R&D Systems (Minneapolis, MN), respectively.
Lentiviral pLKO.1-puro short hairpin RNA vectors target-
ing TNKS (Clone ID: TRCN0000040186) and TNKS2
(Clone ID: TRCN0000053239), as well as the non-
targeting control vector (product number: SHC002),
were purchased from Sigma. Lentiviral vectors
were produced by LipofectAMINE 2000 (Invitrogen
Carlsbad, CA)-mediated transfection of 293 T cells.
TOPflash reporter assay
Cells at 80 % confluence were transiently transfected
with TOPflash or FOPflash plasmids (Millipore Billerica,
MA) using LipofectAMINE 2000. Luciferase activity was
assayed 48 or 72 h after transfection with the Luciferase
Assay System (Promega), using a GloMax 96 microplate
luminometer (Promega).
Biological assays
Prior to all of the following experimental procedures
and if not otherwise specified, cells were pre-incubated
with TNKS/2 inhibitors for 24 h in 2 % fetal bovine
serum (FBS)-containing medium; RPMI supplemented
with 2 % FBS and HGF (50 ng/mL) was used as chemo-
attractant. Unless stated differently, TNKS/2 inhibitors
were used at a 10 μM concentration.
For invasion studies, 1 × 105 cells in 100 μL of serum-
deprived RPMI were seeded onto Transwell chamber in-
serts (Costar Thermo Fisher, Waltham, MA) with 8-μM
pore size membranes coated with Matrigel (R&D Sys-
tems) (15 μg/cm2). HGF-conditioned medium was added
to the lower compartment with or without TNKS/2 in-
hibitors. Cells were allowed to migrate at 37 °C for 24 h.
After mechanical removal of the non-invading cells, the
proportion of cells that had migrated to the lower side
of the membrane were fixed with 11 % glutaraldehyde,
stained with 0.1 % crystal violet, and quantified using
ImageJ.
For wound healing assays, cell monolayers were
scratched with a pipette tip. Alternatively, IBIDI
Culture-Inserts (Martinsried, Germany) with a well-
defined cell-free gap were used according to the manu-
facturer’s guidelines. In both cases, wound-edge cells
were stimulated with HGF and allowed to migrate for
24 h with or without TNKS/2 inhibitors prior to crystal
violet staining and ImageJ quantification.
Proliferative response was assessed as described
previously [47]. On day 0, cells were plated at clonal
density (10 cells/μL) in complete medium. On day 1,
serially diluted TNKS/2 inhibitors (dose range: 0 to
10 μM) or vehicle (dimethyl sulfoxide) were added to
the cells. Drug-containing medium was renewed after
48 h. On day 4, cell viability was measured by
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CellTiter-Glo (Promega) using a Victor X4 microplate
luminometer (PerkinElmer Waltham, MA).
Immunofluorescence, confocal microscopy, and
morphometric quantitation
Cells were seeded onto glass coverslips coated with
3 μg/mL fibronectin (Sigma), fixed in 4 % paraformalde-
hyde for 10 min, permeabilized with ice-cold methanol
for 1 min, and incubated with primary antibodies for 1 h
at room temperature, followed by a 30-min staining with
Alexa Fluor 555-conjugated or 488-conjugated secondary
antibodies (Molecular Probes Thermo Fisher). Nuclei
were counterstained with 4',6-diamidino-2-phenylin-
dole (Roche Applied Science Penzberg, Germany). Im-
ages were acquired by sequential scanning using the
Leica TCS SPE confocal system and a DM 5500 Q
microscope (Leica Microsystems Wetzlar, Germany)
equipped with a 63× objective. For quantification of
lamellipodia extensions, the diffuse cytoplasmic fluor-
escence of APC was used to trace the silhouette of
individual cells facing the wound; cells exhibiting
discernible membrane projections were scored as
lamellipodia-positive. APC-decorated protrusions were
counted by dividing the number of cortical APC
events by the total number of lamellipodia. To detect
polymerized tubulin (i.e., intact microtubules), we
used custom-made image analysis algorithms written
in MATLAB. Images were filtered with a linear rotat-
ing kernel filter [48] and then processed with a multi-
scale vessel enhancement filter [49]. To quantify the
differences in tubulin staining distribution and
morphology we measured the total area occupied by
microtubules (a measure of the amount of polymer-
ized tubulin) relative to the total cell area.
Time-lapse videomicroscopy
Confluent A549 cells were seeded on glass bottom
dishes (Willcowells Amsterdam, The Netherlands),
scratched with a pipette tip, and treated with HGF with
or without TNKS/2 inhibitors. Phase-contrast images
were taken every 12 s for 60 min with a 20× objective
using a Leica AF6000LX workstation equipped with a
thermostatic and CO2-controlled chamber. Movies were
generated by the LAS AF Leica Application Suite soft-
ware (Leica) and compressed to 20 frames per second.
Real Time RT-PCR
Total RNA was extracted with the RNeasy Mini Kit
(QiagenHilden, Germany) and reverse-transcribed using
High Capacity cDNA reverse transcription (Life Tech-
nologies Carlsbad, CA). Results were normalized to the
average of three housekeeper genes. The TaqMan probes
(Life Technologies) were as follows: Hs99999903_m1
(ACTB), Hs00427621_m1* (TBP), Hs00824723_m1*
(UBC), Hs00186671_m1 (TNKS), Hs00228829_m1
(TNKS2), Hs00610344_m1* (AXIN2), Hs00173664_m1
(LGR5), Hs00905030_m1* (MYC), Hs00256886_m1*
(HOXB9), and Hs01547250_m1* (LEF1).
Statistical analysis
Statistical analyses were performed by two-tailed Student’s
t-test, Chi-square test, and two-way analysis of variance.
P < 0.05 was considered statistically significant.
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